These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 10868686

  • 1. Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention.
    Li M, Lotan R, Levin B, Tahara E, Lippman SM, Xu XC.
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):545-9. PubMed ID: 10868686
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 3. Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents.
    Rodríguez-Burford C, Barnes MN, Oelschlager DK, Myers RB, Talley LI, Partridge EE, Grizzle WE.
    Clin Cancer Res; 2002 Jan 15; 8(1):202-9. PubMed ID: 11801560
    [Abstract] [Full Text] [Related]

  • 4. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 5. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway.
    Jiang XH, Lam SK, Lin MC, Jiang SH, Kung HF, Slosberg ED, Soh JW, Weinstein IB, Wong BC.
    Oncogene; 2002 Sep 05; 21(39):6113-22. PubMed ID: 12203123
    [Abstract] [Full Text] [Related]

  • 6. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
    Wei WQ, Qiao YL.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb 05; 23(1):78-82. PubMed ID: 12905826
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC, Kania J, Burnat G, Hahn EG.
    J Physiol Pharmacol; 2006 Dec 05; 57 Suppl 12():15-24. PubMed ID: 17244951
    [Abstract] [Full Text] [Related]

  • 14. Failure of apoptosis and activation on NFkappaB by celecoxib and aspirin in lung cancer cell lines.
    Gradilone A, Silvestri I, Scarpa S, Morrone S, Gandini O, Pulcinelli FM, Gianni W, Frati L, Aglianò AM, Gazzaniga P.
    Oncol Rep; 2007 Apr 05; 17(4):823-8. PubMed ID: 17342322
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

  • 17. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
    Strul H, Arber N.
    Isr Med Assoc J; 2000 Sep 15; 2(9):695-702. PubMed ID: 11062772
    [Abstract] [Full Text] [Related]

  • 18. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 19. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP, Shi LY, Lu WH, Su YH, Li YY, Xu SQ.
    J Gastroenterol Hepatol; 2004 Jun 15; 19(6):638-42. PubMed ID: 15151617
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.